Agios Pharmaceuticals
AGIO
AGIO
159 hedge funds and large institutions have $1.7B invested in Agios Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 47 increasing their positions, 58 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
–
Holders Change %
0%
% of All Funds
2.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
47
Reduced
58
Closed
21
Calls
$8.77M
Puts
$10.1M
Net Calls
-$1.3M
Net Calls Change
+$5.76M
Top Buyers
| 1 |
1
First Trust Advisors
Wheaton,
Illinois
|
$47M |
| 2 |
2
Norges Bank
Oslo,
Norway
|
$14.4M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$29.4M |
| 4 |
4
Axa
Paris,
France
|
$5.85M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$92.8M |
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$140M |
| 2 |
BG
2
Bellevue Group
Kuesnacht,
Switzerland
|
$120M |
| 3 |
3
BlackRock
New York
|
$151M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$78.6M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$1.34M |
